Paracetamol Fresenius Kabi

Paracetamol, the active ingredient in Paracetamol Fresenius Kabi, is an analgesic presented as a intravenous solution for parenteral use. It is used to relieve pain and reduce fever in hospital settings, particularly in adults and children when oral administration is not feasible. GNH USA supplies Paracetamol Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Paracetamol Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Paracetamol Fresenius Kabi is an analgesic and antipyretic used in the following clinical situations:

- Post‑operative pain: provides effective relief of moderate pain following surgery. - Fever management: reduces elevated body temperature in acute febrile states. - Acute musculoskeletal pain: alleviates pain associated with sprains, strains and other soft‑tissue injuries. - Headache: helps relieve tension‑type and mild migraine‑type headaches. - Dental pain: controls pain after dental procedures. - Cancer‑related pain: used as part of multimodal analgesia for mild to moderate pain in oncology patients.

Paracetamol may cause a range of adverse reactions, most of which are dose‑related or idiosyncratic.

Common Side Effects: - Nausea: mild gastrointestinal upset may occur. - Rash: skin irritation or mild rash. - Elevated liver enzymes: transient increase in hepatic transaminases. - Headache: occasional worsening of headache. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Toxic hepatitis: liver injury that can be life‑threatening. - Anaphylaxis: acute allergic reaction with airway compromise. - Blood dyscrasias: rare blood cell abnormalities. - Severe skin necrosis: extensive skin damage.

Paracetamol should be used with awareness of patient‑specific factors and proper handling.

- Liver disease: avoid or adjust use in patients with hepatic impairment. - Alcohol use: limit concurrent alcohol intake to reduce hepatotoxic risk. - Renal impairment: monitor kidney function in patients with chronic kidney disease. - Concomitant medications: review other drugs containing paracetamol to prevent overdose. - Pregnancy and lactation: use only if clearly indicated and prescribed by a healthcare professional. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Paracetam/   

---

         i    t  \\